Caring about stability and compatibility.
Hasegawa
G R
GR
D001831:Body Temperature; D002130:Calcium Phosphates / Q000009:adverse effects / Q000737:chemistry*; D011232:Chemical Precipitation; D004344:Drug Incompatibility; D004355:Drug Stability; D006801:Humans; D010288:Parenteral Nutrition / Q000009:adverse effects*; D010595:Pharmacists; D014481:United States; D014486:United States Food and Drug Administration
D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous